| Income Statement |
| Total Revenue | 62.60M |
|
| Revenues (USD) | 62.60M |
| Cost of Revenue | 31.77M |
| Gross Profit | 30.83M |
| Operating Expenses | 6.59M |
| Research and Development Expense | 2.89M |
| Selling, General and Administrative Expense | 3.70M |
| Operating Income | 24.23M |
| Interest Expense | 307.00K |
| Income Tax Expense | 8.66M |
| Net Income | 13.86M |
| Net Income Common Stock | 13.86M |
| Net Income Common Stock (USD) | 13.86M |
| Consolidated Income | 13.86M |
| Earnings per Basic Share | 0.16 |
| Earnings per Basic Share (USD) | 0.16 |
| Earnings per Diluted Share | 0.15 |
| Earning Before Interest & Taxes (EBIT) | 22.83M |
| Earning Before Interest & Taxes (USD) | 22.83M |
| Weighted Average Shares | 87.99M |
| Weighted Average Shares Diluted | 90.47M |
| Balance Sheet |
| Cash and Equivalents | 71.91M |
| Cash and Equivalents (USD) | 71.91M |
| Investments | 40.11M |
| Investments Current | 40.11M |
| Trade and Non-Trade Receivables | 6.29M |
| Current Assets | 156.60M |
| Property, Plant & Equipment Net | 127.00M |
| Total Assets | 296.51M |
| Current Liabilities | 50.40M |
| Total Liabilities | 106.24M |
| Accumulated Retained Earnings (Deficit) | 6.13M |
| Accumulated Other Comprehensive Income | 2.30M |
| Shareholders Equity | 190.27M |
| Shareholders Equity (USD) | 190.27M |
| Assets Non-Current | 139.91M |
| Inventory | 50.42M |
| Liabilities Non-Current | 55.83M |
| Trade and Non-Trade Payables | 36.85M |
| Tax Liabilities | 6.70M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.64M |
| Net Cash Flow from Financing | -2.96M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.06M |
| Capital Expenditure | -6.25M |
| Issuance (Purchase) of Equity Shares | 72.00K |
| Net Cash Flow from Investing | -44.78M |
| Net Cash Flow - Investment Acquisitions and Disposals | -38.52M |
| Net Cash Flow from Operations | 26.00M |
| Effect of Exchange Rate Changes on Cash | 677.00K |
| Share Based Compensation | 1.47M |